Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-02-005448
Filing Date
2002-05-14
Accepted
2002-05-14 15:08:08
Documents
2
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d96803a1e10-ka.txt 10-K/A 35222
3 CONSENT OF KPMG d96803a1ex23-1.txt EX-23.1 936
  Complete submission text file 0000950134-02-005448.txt   37845
Mailing Address 2579 MIDPOINT DR FORT COLLINS CO 80525
Business Address 2579 MIDPOINT DR FORT COLLINS CO 80525 3034825868
ATRIX LABORATORIES INC (Filer) CIK: 0000809875 (see all company filings)

EIN.: 841043826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-18231 | Film No.: 02646285
SIC: 2834 Pharmaceutical Preparations